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Introduction {#sec1}
============

Spermatogonial stem cells (SSCs) are pivotal for maintaining the lifelong sperm production of mammalian males. They maintain a delicate balance between self-renewal and commitment to differentiate for sperm production. Mouse SSCs can be maintained under culture conditions, continuing to proliferate for up to 2 years without losing their spermatogenic ability as well as maintaining genetic, epigenetic, and karyotypic stability. The cultured SSCs, named germline stem (GS) cells, are now useful in research on various aspects of spermatogenesis. ([@bib9; @bib16]). In order to make GS cells more widely applicable for the study of spermatogenesis at the genetic and molecular levels, it is desirable to be able to modify their genome without disturbing their spermatogenic ability. In fact, this was shown to be possible by the transfection of genes into GS cells ([@bib11]) or by targeting particular genes in GS cells by homologous recombination ([@bib12]). Successfully treated GS cells were selected during the subsequent cultivation and transplanted into the seminiferous tubules of host mice to produce genome-modified sperm. These results proved that GS cells, like embryonic stem cells (ESCs), can be used as genetically modified cells for the production of animals with modified genomes. Thus, GS cells appear to be a useful tool not only for the study of spermatogenesis but also for many other areas of biological research. However, it is rather difficult to manipulate the genome of GS cells compared to ESCs because of their low transfection efficiency, slow cycling, and difficulty in cloning ([@bib11; @bib13; @bib25]). Thus, targeted genome-modifying experiments using GS cells are not common, and, to the best of our knowledge, only three reports have been published ([@bib8; @bib12; @bib14]).

Recently, new genome-modifying methods using sequence-specific endonucleases, such as zinc-finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), and clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 9 (CRISPR/Cas9) systems, were developed one after another ([@bib5]). In addition, gene-targeting experiments with these nuclease systems were very recently reported to be successful in SSC lines ([@bib4; @bib26; @bib3]).

In the present study, we adopted the double-nicking system of CRISPR/Cas9 and tested it, along with TALEN, on GS cells. Our results demonstrated that these artificial endonucleases are powerful tools for genetic-modification experiments in GS cells, providing an effective way to study the genetic mechanism of spermatogenic failure in particular.

Results {#sec2}
=======

Preparation of TALEN and CRISPR/Cas9 Plasmids Targeting the *Rosa26* Locus {#sec2.1}
--------------------------------------------------------------------------

We designed TALEN and CRISPR/Cas9 constructs targeting a site in the first intron of the *Rosa26* locus that was previously targeted successfully with the ZFN system ([@bib20]) ([Figure S1](#mmc1){ref-type="supplementary-material"}A). The *Rosa26* locus was chosen because inserted genes will be expressed ubiquitously without any additional effects on the characteristics of target cells ([@bib27]). Thus, the targeted GS cells were expected to maintain spermatogenic competency. We used the Platinum TALEN plasmid, which has enhanced cleavage activity compared to conventional TALEN ([@bib23]). As for CRISPR/Cas9, we chose the pX335 CRISPR/Cas9 expression vector, which uses a double-nicking strategy, by which the occurrence of a double-strand break (DSB) becomes more specific and accurate ([@bib18; @bib21]). To confirm the target-site-specific cutting efficiency of the TALEN and CRISPR/Cas9-expressing vectors, we performed a Surveyor nuclease assay with the cell line 15P-1, which confirmed their accurate and sufficient cutting efficiency ([Figure S1](#mmc1){ref-type="supplementary-material"}B).

Gene Targeting of the *Rosa26* Locus Using TALEN and CRISPR/Cas9 {#sec2.2}
----------------------------------------------------------------

The construct of the targeting vector was composed of a splice acceptor, an EGFP, internal ribosome entry sites, and puromycin-resistant gene sequences, sequentially connected in this order and flanked with short homologous sequences on both the 5′ and 3′ sides ([Figure 1](#fig1){ref-type="fig"}A). When gene targeting is successful, the targeted GS cells express GFP and become resistant to puromycin.

We performed transfection with the targeting vector together with the TALEN or CRISPR/Cas9-expressing vector by electroporation of GS cells derived from the wild-type mouse. Approximately 2 weeks after electroporation, the selection of GS cells with puromycin was initiated. Puromycin-resistant colonies became apparent in ∼1 week, and some of them were picked up for cloning without checking GFP expression. We obtained 12 and 8 clones of transfected GS cells with TALEN and CRISPR/Cas9, respectively. Excluding one clone produced by TALEN, every GS cell clone expressed GFP ([Figure 1](#fig1){ref-type="fig"}B). We used PCR genotyping to examine whether the *Rosa26*-targeting construct was integrated into the target site. All of the 11 and 8 GFP-expressing clones induced by TALEN and CRISPR/Cas9, respectively, showed the correct insertion of the target sequence into the *Rosa26* locus ([Figure 1](#fig1){ref-type="fig"}C). Among them, 8 out of the 11 clones and 5 out of the 8 clones showed homozygous insertion ([Figure 1](#fig1){ref-type="fig"}C). Southern blotting analysis demonstrated that there was no integration of the donor construct other than at the target site ([Figure 1](#fig1){ref-type="fig"}D). Collectively, targeting efficiencies mediated by TALEN and CRISPR/Cas9 were quite high: 11 clones out of 12 and all 8 clones, respectively ([Table 1](#tbl1){ref-type="table"}). Thus, these results indicate that genome editing mediated by the TALEN or CRISPR/Cas9 double-nicking system was highly effective in introducing a transgene at target site in the genome of GS cells.

Spermatogenic Ability of Targeted GS Cells {#sec2.3}
------------------------------------------

We tested whether those GS cells with a target construct at the *Rosa26* site (*Roas26*-GS cell) remain as functional SSCs and differentiate into competent sperm. We transplanted lines of *Rosa26*-GS cells into the testes of *W/W*^*v*^ (W) mice whose testes contain very few germ cells because of genetic defects in the *c-kit* gene, making them an ideal host testis. The transplanted *Rosa26*-GS cells colonized the seminiferous tubules and formed stretches of colonies that expressed GFP ([Figure 2](#fig2){ref-type="fig"}A). By histological observation, we confirmed that those colonies supported spermatogenesis up to sperm formation. The immunohistologic features, as well as regular histological findings on periodic acid-Schiff (PAS) stain, demonstrated normal spermatogenesis ([Figures 2](#fig2){ref-type="fig"}B, 2D, and 2E). When testis tissue was dissociated, sperm were obtained ([Figure 2](#fig2){ref-type="fig"}C). In summary, we transplanted 11 and 4 clones of *Rosa26*-GS cells of TALEN and CRISPR/Cas9, respectively, resulting in 9 and 4 clones giving rise to spermatogenesis, respectively. The two clones of *Rosa26*-GS cells with the TALEN procedure showed neither colonization nor spermatogenesis in the W mouse testes, for unknown reasons.

Next, we tested the fertility of those sperm by intracytoplasmic sperm injection (ICSI). We chose the clones of TALENs \#8 and \#9 ([Figures 1](#fig1){ref-type="fig"}C and 1D). All (n = 113) oocytes fertilized by ICSI developed into the two-cell stage on the next day ([Table S1](#mmc1){ref-type="supplementary-material"}). Following embryo transfer, 8 and 23 offspring were delivered from clones \#8 and \#9, respectively, and all grew healthily ([Figure 2](#fig2){ref-type="fig"}F; [Table S1](#mmc1){ref-type="supplementary-material"}). As both clones were targeted homozygously ([Figure 1](#fig1){ref-type="fig"}C), all offspring carried the inserted GFP heterozygously ([Figure S2](#mmc1){ref-type="supplementary-material"}A) and expressed GFP throughout the body ([Figure 2](#fig2){ref-type="fig"}F). When their reproductive potential was examined by brother-sister mating, they gave birth to offspring, proving its reproductive competency. The second-generation progeny also grew normal and were healthy ([Figures S2](#mmc1){ref-type="supplementary-material"}B--S2D). These results demonstrate that gene modification of GS cells using a TALEN and CRISPR/Cas9 double-nicking system did not affect the characteristics of GS cells, both as stem and spermatogenic cells.

Gene Targeting of *Stra8* Gene Using CRISPR/Cas9 {#sec2.4}
------------------------------------------------

The genetic modification techniques when applied to GS cells could be a useful means to examine the function of particular genes during spermatogenesis. Using the double-nicking CRISPR/Cas9, we tried to disrupt the gene of *Stimulated by retinoic acid gene 8* (*Stra8*) by inserting the targeting vector sequence. *Stra8* expression is induced by retinoic acid (RA) in spermatogonia and is responsible for entry into meiosis ([@bib2; @bib28]). We constructed a CRISPR/Cas9-expressing vector, which includes sequence of guide RNA specific to a site in the fourth exon of the *Stra8* gene ([Table S2](#mmc1){ref-type="supplementary-material"}), and a targeting vector, which contained tdTomato fluorescence, PGK promoter, and Puro sequences ([Figure 3](#fig3){ref-type="fig"}A). We used these three vectors to transfect GFP-GS cells that express GFP constitutively. Amounts of vector DNA transfected were 2 and 6 μg of CRISPR/Cas9 and targeting vectors, respectively, or double doses of them. Nine colonies resistant to puromycin were picked up from each plasmid dosage group, resulting in 18 clones in total (termed *Stra8*-GS cells). Each clone was examined by PCR genotyping and Southern blotting to show that the *Stra8*-targeting construct had been integrated into the target site correctly, without random integration ([Figures 3](#fig3){ref-type="fig"}B and 3C). The homologous insertion was noted in three out of nine clones and six out of nine clones, respectively, for each dose set of vectors ([Figure 3](#fig3){ref-type="fig"}B).

When *Stra8*-GS cells were cultured in a medium with RA added for 2 days, almost all *Stra8*-GS cells expressed tdTomato, confirming that the expression of the inserted construct was induced by RA ([Figure 3](#fig3){ref-type="fig"}D). We then chose a line of homozygously knocked in *Stra8*-GS cells and transplanted them into the testes of W mice. Eighty-four days after, on analysis, the recipient testis showed extensive colonization by GS cells, appearing as tubules colored with GFP ([Figure 3](#fig3){ref-type="fig"}E). The colonized cells, however, appeared to be restricted to the periphery of the seminiferous tubules, indicating that they were located on the basement membrane without differentiation to the inside of the tubules. Histological analysis showed that there were tubules containing spermatogonia lining the basement membrane with no progression of spermatogenesis ([Figure 3](#fig3){ref-type="fig"}F), which was exactly the same as the phenotype of *Stra8*-deficient mice ([@bib2]). Furthermore, we performed an immunohistological examination with antibodies to tdTomato and GFP and found that the expression of tdTomato in spermatogonia was different from tubule to tubule ([Figure 3](#fig3){ref-type="fig"}G). This observation is consistent with a previous report that the expression of *Stra8* was periodic in spermatogonia and spermatocytes, depending on the wave of the seminiferous epithelium ([@bib28]). Together, these results demonstrate that CRISPR/Cas9-mediated gene disruption is effective in GS cells, the effects of which could appear as a particular phenotype in spermatogenesis following transplantation into the host testis.

Discussion {#sec3}
==========

In the present study, we succeeded in genome modification of the *Rosa26* locus and *Stra8* gene using TALEN or CRISPR/Cas9 systems, with extremely high-level efficiency and accuracy. The accuracy of CRISPR/Cas9 was comparable to that of TALEN and was actually perfect, probably owing to the double-nicking system we used.

In a previous report, the gene-targeting efficiency in GS cells without genome-editing technology was as low as 1.7%, as 2 out of 120 clones were selected ([@bib12]). Using TALEN and CRISPR/Cas9 in the present study, the targeting efficiency appeared surprisingly high, because most of the picked-up colonies showed successful gene targeting. This efficiency is comparable to or even higher than that in other reports using TALEN with human ESCs, which showed 42% to 100% ([@bib7]). These results confirm that DSB induction can promote homologous recombination significantly in GS cells as well.

Very recently, two groups reported gene-targeting experiments with GS cells using ZFN and CRISPR/Cas9 systems, respectively ([@bib4; @bib26]). Fanslow et al.'s group reported to have succeeded in genome editing in GS cells with the ZFN system. The targeted GS cells, however, appeared to have lost their spermatogenic ability, being unable to differentiate into sperm following transplantation into the host testis. Wu et al.'s group treated a genetic defect of a single-nucleotide deletion in a mutant mouse, which causes cataract, using CRISPR/Cas9 in GS cells. The sequence covering the deletion site was replaced by the 89 bp of single-stranded oligodeoxynucleotides, which resulted in correction of the mutation. The treated GS cells, after transplantation into the host mouse testis, differentiated into haploid cells, which were used for the production of progeny not showing cataract. These two reports demonstrated that GS cells, as well as many other somatic cells or cell lines, can be genomically manipulated with those sequence-specific endonuclease systems. The latter one, in particular, showed that the correction of a mutated sequence was possible in GS cells, whereby genetic diseases caused by such mutations can be eliminated from subsequent generations.

In the present study, we showed that both TALEN and double-nicking CRISPR/Cas9 were effective for genome editing in GS cells. In fact, we demonstrated that 2.8--4.7 kbp of transgenes could be successfully introduced accurately into the target site in the genome of GS cells. This result suggests that genome-editing technology in GS cells allows us to repair more extensive mutations than those involving single nucleotides. More importantly, our study demonstrated that the *Rosa26*-GS cells retained full capacity for complete spermatogenesis up to the formation of competent sperm, which was not shown in either of the two previous studies. It is noteworthy that GS cells are prone to lose spermatogenic potential, possibly after being cultured under stressful conditions such as overgrowth, repeated freezing and thawing, or high passage numbers. In an extreme case, GS cells not only lose spermatogenic ability but also gain multipotency, turning into ESC-like cells ([@bib10]). In order to make GS cells useful for the study of spermatogenesis, this characteristic of GS cells must be kept in mind. In the present study, we successfully showed that the spermatogenic ability of GS cells was disturbed when the *Stra8* gene was disrupted. This result demonstrated that GS cells can be used to test whether or not a particular gene or genes are functioning in spermatogenesis when cultured under the appropriate conditions.

As was shown in this study, along with many other previous studies, TALEN and double-nicking CRISPR/Cas9 genome-editing techniques are significantly accurate, with only a negligible risk of random gene disruption, in the drug-selected clones. This result indicates that disrupting a particular gene without disturbing any other genes in GS cells could replace gene-manipulating technologies with ESCs in the study of spermatogenesis. When GS cells of species other than mice become available for gene targeting as well, it may become possible to study the role of particular genes in their spermatogenesis, which would be rather difficult or practically impossible with ESC technology. In fact, culturing of the SSCs of the rat, hamster, and rabbit was reported to be feasible ([@bib6; @bib15; @bib17; @bib22]), making this research strategy realistic. In addition, whole-genome sequencing is now available, owing to the many technological innovations in that field. Based on such a huge volume of genome information along with sophisticated analysis methods, genetic analysis of infertile patients (azoospermia in particular) could reveal genes responsible for spermatogenic failure. The genome-modifying technologies shown in this study will be extremely useful to examine such candidate genes responsible for spermatogenic defects in the future.

Experimental Procedures {#sec4}
=======================

Animals and Culture of GS Cells {#sec4.1}
-------------------------------

To establish wild-type GS and GFP-GS cells, male C57BL/6 (CLEA Japan) and C57BL/6-Tg (*CAG/Acr-GFP*) ([@bib19]) transgenic mice, respectively, were mated with wild-type ICR females (CLEA Japan) to produce F1 pups. The testes of F1 pups were dissected out and used as a source of GS cells. The culture medium used for GS cells was StemPro-34 based ([@bib9]), with minor modifications ([@bib24]). Wild-type GS and GFP-GS cells were used for targeting experiments of *Rosa26* and *Stra8*, respectively. WBB6F1-*W/W*^*v*^ (Japan SLC), at 6--15 weeks old, were used as recipients for spermatogonial transplantation. *W/W*^*v*^ allows colonization of GS cells of ICR/B6 background without apparent rejection ([@bib1]). The spermatogenic ability of GS cell lines was checked by transplantation into the testes of *W/W*^*v*^ before using for targeting experiments ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). All animal experiments conformed to the *Guide for the Care and Use of Laboratory Animals* and were approved by the Institutional Committee of Laboratory Animal Experimentation (Animal Research Center of Yokohama City University, Yokohama, Japan).

Gene Targeting of GS Cells {#sec4.2}
--------------------------

GS cells used for targeting to Rosa26 and Stra8 were at passages 6 and 8, respectively. They were harvested using 0.25% trypsin, and 1.5--4 × 10^6^ cells resuspended in T solution of Cell Line Nucleofector Kit were electroporated with 6 μg of targeting vector plasmids and 2 μg of each TALEN or CRISPR/Cas9-expressing plasmid using Nucleofector 2b with program A-023. Selection with puromycin (0.15 μg/ml) was performed 10--14 days after electroporation. When puromycin-resistant colonies expanded, usually at ∼4 weeks after electroporation, we picked up individual colonies using a micropipette (P200 pipetman) under an inverted microscope for successive culturing.
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![Gene Targeting of the *Rosa26* Locus in GS Cells\
(A) Schematic overview of the targeting strategy for the *Rosa26* locus. Arrows (P1, P2, and P3) are primer sites for PCR genotyping. P1 and P2 primers are located at outside the region of homology arms. The P3 primer is located in the transgene. Expected sizes of PCR products are 2,552 bp in wild-type and 1,678 bp in targeted alleles. The probe used for Southern blot analysis is shown as a green bar. SA, splicing acceptor; IRES, internal ribosomal entry site; Puro, puromycin-resistance gene.\
(B) Targeted GS cells using TALEN express GFP, demonstrated by a merged image of GFP (green) and differential interface contrast (DIC).\
(C) Genotyping PCR of GS cells targeted using TALEN or CRISPR/Cas9, selected by puromycin treatment, and picked up without confirming GFP expression. The M and W lanes show a 200-bp ladder marker and wild-type controls, respectively. Asterisks indicate homozygously targeted clones. WT indicates the position of the band derived from the original wild-type *Rosa26* locus, while TA indicates that from the targeted allele.\
(D) Southern blot analysis of GS cells targeted with TALEN or CRISPR/Cas9. *XbaI*-digested genomic DNA was hybridized with a GFP probe. Expected fragment size is 7 kb.\
Scale bar, 100 μm (B).](gr1){#fig1}

![Spermatogenic Ability of Targeted GS Cells\
(A) Recipient testes transplanted with GS cells targeted by TALEN and CRISPR/Cas9 contained seminiferous tubules expressing GFP, which indicates GS cell colonization. A non-transplanted recipient testis (W mouse) did not show GFP expression.\
(B) Immunostaining of recipient testis tissue cryosections, transplanted with *Rosa26*-GS cells targeted by TALEN. Peanut agglutinin (PNA), which reacts with the acrosome, appears as red. Anti-GFP (green) and counterstain with Hoechst dye (blue) were merged.\
(C) Flagellated sperm derived from mechanically dissociated host testis transplanted with *Rosa26*-GS cells targeted with TALEN.\
(D) Immunostaining of recipient testis tissue transplanted with Rosa26-GS cells targeted by CRISPR. PNA (red), anti-GFP (green), and counterstain with Hoechst dye (blue) were merged.\
(E) A recipient testis transplanted with GS cells targeted by CRISPR/Cas9 shows extensive colonization on day 159 after transplantation (left). This testis processed for histological examination showed normal spermatogenesis with PAS stain (right).\
(F) Offspring obtained using the ICSI procedure with sperm derived from two *Rosa26*-GS cell clones (\#8 and \#9) targeted with TALEN. GFP expression throughout the bodies of the offspring was confirmed under UV light.\
Scale bars represent 1 mm (A and E, left), 200 μm (E, right), 100 μm (B), 50 μm (D), or 20 μm (C).](gr2){#fig2}

![Targeting of the *Stra8* Gene in GS Cells Using CRISPR/Cas9\
(A) Schematic overview of the targeting strategy for the *Stra8* gene. Arrows (P1, P2, and P3) show primer sites for the genotyping PCR. P1 and P2 primers are located outside the region of the homology arm. The P3 primer is located in the transgene. Expected sizes of the PCR products are 1,687 bp in wild-type and 1,542 bp in targeted alleles. The probe used for Southern blot analysis is shown as a green bar.\
(B) PCR genotyping of *Stra8*-GS cells targeted with CRISPR/Cas9. The leftmost lane shows a 200-bp ladder marker. The W lane shows wild-type controls. Asterisks indicate homozygously targeted clones.\
(C) Southern blot analysis of *Stra8*-GS cells. *SpeI*-digested genomic DNA was hybridized with the *tdTomato* probe. The expected fragment size is 6.6 kb.\
(D) Expression of the tdTomato was induced in *Stra8*-GS cells by RA addition to the medium in 2 days. A merged image of tdTomato (red), GFP (green), and DIC is shown.\
(E) A recipient testis transplanted with *Stra8*-GS cells shows extensive colonization of the GS cells. The inset shows a magnified view of the same testis.\
(F) H&E staining of a cryosection of the recipient testis, showing no meiotic differentiation.\
(G) Immunostaining of recipient testis tissue transplanted with *Stra8*-GS cells, confirming colonization of the GS cells, some of which express tdTomato. tdTomato (red), anti-GFP (green), and counterstain with Hoechst dye (blue) were merged. The red and white dotted lines delineate seminiferous tubules containing tdTomato-positive and tdTomato-negative spermatogonia, respectively.\
Scale bars represent 1 mm (E), 100 μm (D), or 50 μm (F and G).](gr3){#fig3}

###### 

Summary of Targeting Experiments Using TALEN and CRISPR/Cas9

                                         Targeting Vector          No. of Clones Analyzed   No. of Non-targeted Clones   No. of Targeted Clones   No. of Random Integration   Homozygous Insertion
  -------------------------------------- ------------------------- ------------------------ ---------------------------- ------------------------ --------------------------- ----------------------
  TALEN                                  Rosa-SA-GFPiPuro          12                       1                            11                       0                           8/11
  CRISPR                                 Rosa-SA-GFPiPuro          8                        0                            8                        0                           5/8
  CRISPR                                 Stra8-tdTomato-PGK-Puro   18                       0                            18                       0                           3/9
  6/9[a](#tblfn1){ref-type="table-fn"}                                                                                                                                        

Double doses of CRISPR/Cas9 and targeting vectors were used for transfection.
